Skip to main content
Top
Published in: Drugs & Aging 9/2003

01-08-2003 | Original Research Article

NSAID and Aspirin Use by the Elderly in General Practice

Effect on Gastrointestinal Symptoms and Therapies

Authors: Dr Alberto Pilotto, Marilisa Franceschi, Gioacchino Leandro, Francesco Di Mario

Published in: Drugs & Aging | Issue 9/2003

Login to get access

Abstract

Background

The relationship between NSAID use and gastrointestinal (GI) symptoms and their treatment in elderly patients is not well defined.

Objectives

To identify the prevalence of specific drug use in elderly outpatients and to identify the relationship between NSAID use and GI disturbances and treatments in elderly subjects treated by their general practitioner (GP).

Settingand participants

The study was carried out by 63 GPs in north-eastern Italy; 3154 elderly subjects were included in the study over a 2-week period.

Design

By using a structured interview, subjects’ medical histories and current medication were identified. In particular, the presence and use pattern (i.e. occasional, ‘acute’ or ‘chronic’) of NSAIDs and/or aspirin (acetylsalicylic acid) were recorded. In all subjects, the presence of upper GI symptoms, i.e. abdominal pain, reflux symptoms and indigestion syndrome, were noted.

Results

The prevalence of drug use was 96.4% (males 96%, females 96.7%). The most prescribed drugs were ACE inhibitors (38%), diuretics (26.7%), NSAIDs and regular-dose aspirin (24.7%), GI drugs (20.6%), and anxiolytics/hypnotics (20.3%). Of 779 subjects who had taken NSAIDs or regular-dose aspirin, 32.9% were ‘chronic’ users, 24.9% were ‘acute’ users and 42.1% occasional users. A significantly higher prevalence of upper GI symptoms was observed in elderly NSAID and low-dose aspirin users compared with non-users (24.9% vs 28% vs 16.6% respectively, p < 0.0001). GI symptoms were reported by 27.6% of ‘chronic’ NSAID users, 22.9% of ‘acute’ users and 24.7% of occasional users. A significantly higher prescription rate for any GI drug was found in NSAID users than in low-dose aspirin users and non-users (24.0% vs 19.6% vs 19.4% respectively, p = 0.007). This difference was mainly because of a higher number of upper GI drugs taken by NSAID users than by low-dose aspirin users and non-users (18.1% vs 16% vs 13.7% respectively, p = 0.004). Multivariate analysis demonstrated that female gender (odds ratio [OR] = 1.32, 95% CI = 1.16–1.44), low-dose aspirin (OR = 1.88, 95% CI = 1.33–2.65), NSAIDs and/or regular-dose aspirin (OR = 1.48, 95% CI = 1.19–1.83) and multiple therapies, i.e. taking more than four drugs per day (OR = 1.42, 95% CI = 1.14–1.77) were risk factors for GI symptoms in elderly outpatients.

Conclusion

NSAIDs and/or aspirin use was very high in this elderly outpatient population. The use of these drugs was significantly associated with a greater number of upper GI symptoms and prescriptions for GI drugs. Educational and clinical strategies need to be implemented in order to reduce the GI impact of NSAID and aspirin use in elderly people.
Literature
1.
go back to reference Nobili A, Tettamanti M, Frattura L, et al. Drug use by the elderly in Italy. Ann Pharmacother 1997; 31: 416–22PubMed Nobili A, Tettamanti M, Frattura L, et al. Drug use by the elderly in Italy. Ann Pharmacother 1997; 31: 416–22PubMed
2.
go back to reference Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995; 123: 195–204PubMed Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995; 123: 195–204PubMed
3.
go back to reference Nygaard HA, Naik M. Drug use in homes for the aged: a comparison between mentally intact and mentally impaired residents. Aging Clin Exp Res 1999; 11: 186–93 Nygaard HA, Naik M. Drug use in homes for the aged: a comparison between mentally intact and mentally impaired residents. Aging Clin Exp Res 1999; 11: 186–93
4.
go back to reference Beyth RJ, Shorr RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging 1999; 14: 231–9PubMedCrossRef Beyth RJ, Shorr RI. Epidemiology of adverse drug reactions in the elderly by drug class. Drugs Aging 1999; 14: 231–9PubMedCrossRef
5.
go back to reference Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admission in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944–8PubMed Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admission in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944–8PubMed
6.
go back to reference Mannese CK, Derkx FHM, De Ridder MAJ, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35–9CrossRef Mannese CK, Derkx FHM, De Ridder MAJ, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35–9CrossRef
7.
go back to reference Gray SL, Sager M, Lestico MR, et al. Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci 1998; 53A: M59–63CrossRef Gray SL, Sager M, Lestico MR, et al. Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci 1998; 53A: M59–63CrossRef
8.
go back to reference Griffin MR, Piper JM, Daugherty JR, et al. Non steroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257–63PubMed Griffin MR, Piper JM, Daugherty JR, et al. Non steroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257–63PubMed
9.
go back to reference Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991; 115: 787–96PubMed Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991; 115: 787–96PubMed
10.
go back to reference Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075–8PubMedCrossRef Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075–8PubMedCrossRef
11.
go back to reference Hawkey CJ, Cullen DJE, Greenwood DC, et al. Prescribing of nonsteroidal anti-inflammatory drugs in general practice: determinants and consequences. Aliment Pharmacol Ther 1997; 11: 293–8PubMedCrossRef Hawkey CJ, Cullen DJE, Greenwood DC, et al. Prescribing of nonsteroidal anti-inflammatory drugs in general practice: determinants and consequences. Aliment Pharmacol Ther 1997; 11: 293–8PubMedCrossRef
12.
go back to reference Smalley WE, Griffin MR, Fought RL, et al. Excess costs from gastrointestinal diseases associated with nonsteroidal anti-inflammatory drugs. J Gen Intern Med 1996; 11: 461–9PubMedCrossRef Smalley WE, Griffin MR, Fought RL, et al. Excess costs from gastrointestinal diseases associated with nonsteroidal anti-inflammatory drugs. J Gen Intern Med 1996; 11: 461–9PubMedCrossRef
13.
go back to reference L’informatore farmaceutico 1998. OEMF International, Milano 1998. Guidelines for ATC-classification. NLN-publication No.16. Uppsala: Nordic Council on Medicines, 1985 L’informatore farmaceutico 1998. OEMF International, Milano 1998. Guidelines for ATC-classification. NLN-publication No.16. Uppsala: Nordic Council on Medicines, 1985
14.
go back to reference La Porte JR, Carnè X, Vidal X, et al. Upper gastrointestinal bleeding in relation to previous use of analgesics and nonsteroidal anti-inflammatory drugs. Lancet 1991; 337: 85–9CrossRef La Porte JR, Carnè X, Vidal X, et al. Upper gastrointestinal bleeding in relation to previous use of analgesics and nonsteroidal anti-inflammatory drugs. Lancet 1991; 337: 85–9CrossRef
15.
go back to reference Dimenas E, Glise H, Hallerback B, et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroentrol 1995; 30: 1046–52CrossRef Dimenas E, Glise H, Hallerback B, et al. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroentrol 1995; 30: 1046–52CrossRef
16.
go back to reference Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the gastrointestinal symptoms rating scale (GSRS) in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7: 75–83PubMedCrossRef Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the gastrointestinal symptoms rating scale (GSRS) in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7: 75–83PubMedCrossRef
17.
go back to reference Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684–9PubMed Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684–9PubMed
18.
go back to reference Renner EA, Engle VF, Graney MJ, et al. Prevalence and predictors of regularly scheduled prescription medications of newly admitted nursing home residents. J Am Geriatr Soc 1992; 40: 232–6PubMed Renner EA, Engle VF, Graney MJ, et al. Prevalence and predictors of regularly scheduled prescription medications of newly admitted nursing home residents. J Am Geriatr Soc 1992; 40: 232–6PubMed
19.
go back to reference Willis P, Claesson CB, Fratiglioni L, et al. Drug use by demented and non-demented elderly people. Age Ageing 1997; 26: 382–91 Willis P, Claesson CB, Fratiglioni L, et al. Drug use by demented and non-demented elderly people. Age Ageing 1997; 26: 382–91
20.
go back to reference Walop W, Amos S, Dalziel W, et al. Prescription and nonprescription drug use among high-risk community-dwelling seniors in Ottawa-Carleton. Can J Clin Pharmacol 1999; 6: 93–100PubMed Walop W, Amos S, Dalziel W, et al. Prescription and nonprescription drug use among high-risk community-dwelling seniors in Ottawa-Carleton. Can J Clin Pharmacol 1999; 6: 93–100PubMed
22.
go back to reference Chrischilles EA, Lemke JH, Wallace RB, et al. Prevalence and characteristics of multiple analgesic drug use in an elderly study group. J Am Geriatr Soc 1990; 38: 979–84PubMed Chrischilles EA, Lemke JH, Wallace RB, et al. Prevalence and characteristics of multiple analgesic drug use in an elderly study group. J Am Geriatr Soc 1990; 38: 979–84PubMed
23.
go back to reference Singh G, Ramey DR. NSAID induced gastrointestinal complications: the ARAMIS (Arthritis, Rheumatism and Aging Medical Information System) perspective — 1997. J Rheumatol 1998; 25Suppl. 51: 8–16 Singh G, Ramey DR. NSAID induced gastrointestinal complications: the ARAMIS (Arthritis, Rheumatism and Aging Medical Information System) perspective — 1997. J Rheumatol 1998; 25Suppl. 51: 8–16
24.
go back to reference Talley NJ, Evans JM, Fleming KC, et al. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995; 40: 1345–50PubMedCrossRef Talley NJ, Evans JM, Fleming KC, et al. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 1995; 40: 1345–50PubMedCrossRef
25.
go back to reference Pilotto A, Franceschi M, Leandro G, et al. The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly. Eur J Gastroenterol Hepatol 1997; 9: 951–6PubMedCrossRef Pilotto A, Franceschi M, Leandro G, et al. The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly. Eur J Gastroenterol Hepatol 1997; 9: 951–6PubMedCrossRef
26.
go back to reference Pilotto A, Leandro G, Di Mario F, et al. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci 1997; 42: 586–91PubMedCrossRef Pilotto A, Leandro G, Di Mario F, et al. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci 1997; 42: 586–91PubMedCrossRef
27.
go back to reference Wolf MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999; 340: 1888–99CrossRef Wolf MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999; 340: 1888–99CrossRef
28.
go back to reference Pertusi RM, Godwin KS, House JK, et al. Gastropathy induced by nonsteroidal anti-inflammatory drugs: prescribing patterns among geriatric practitioners. J Am Osteopath Assoc 1999; 99: 305–10PubMed Pertusi RM, Godwin KS, House JK, et al. Gastropathy induced by nonsteroidal anti-inflammatory drugs: prescribing patterns among geriatric practitioners. J Am Osteopath Assoc 1999; 99: 305–10PubMed
29.
go back to reference Leandro G, Pilotto A, Franceschi M, et al. Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials. Dig Dis Sci 2001; 46: 1924–36PubMedCrossRef Leandro G, Pilotto A, Franceschi M, et al. Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials. Dig Dis Sci 2001; 46: 1924–36PubMedCrossRef
Metadata
Title
NSAID and Aspirin Use by the Elderly in General Practice
Effect on Gastrointestinal Symptoms and Therapies
Authors
Dr Alberto Pilotto
Marilisa Franceschi
Gioacchino Leandro
Francesco Di Mario
Publication date
01-08-2003
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 9/2003
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200320090-00006

Other articles of this Issue 9/2003

Drugs & Aging 9/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.